---
figid: PMC8843930__fonc-12-821382-g001
figtitle: Toward a Better Classification System for NK-LGL Disorders
organisms:
- Homo sapiens
- Mus musculus
pmcid: PMC8843930
filename: fonc-12-821382-g001.jpg
figlink: /pmc/articles/PMC8843930/figure/f1/
number: F1
caption: Signaling pathways and mutations involved in NK-LGL leukemia pathogenesis.
  STAT3, RAS/MAPK and PI3K/AKT pathways are constitutionally activated in NK-LGL leukemia.
  The PI3K/AKT pathway leads to the activation of m-TOR and NFκB. STAT3 and NFκB promote
  the transcription of anti-apoptotic genes such as bcl-2 ou mcl-1. TNFAIP3 can undergo
  an inactivating mutation of the A20 protein that negatively regulates NFκB. LGLs
  are resistant to Fas mediated apoptosis. A TET2 loss-of-function mutation is found
  in 34% of NK-LGLs. The gene encoding the chemokine CCL22 is mutated in 20% of NK-LGLs.
  Fas, First Apoptosis Signal; FasL, FasLigand; IL, interleukin; IL-R, interleukin-receptor;
  Jak, Janus Kinase; STAT3, Signal transducer and activator of transcription 3; PDGF-BB,
  platelet-derived growth factor BB; MEK, mitogen activated protein kinase; ERK, extracellular-signal-regulated
  kinase; PI3K, phosphatidyl Inositol 3-Kinase; mTOR, mammalian target of rapamycin;
  NFκB, nuclear factor kappa B; Mcl1, Myeloid cell leukemia1; Bcl, B-cell lymphoma
  2; CCL22, C-C Motif Chemokine Ligand 22; 5-mc, 5-methylcytosin; 5hmc, 5-hydroxymethylcytosin;
  TET2, Ten-eleven-translocation 2.
papertitle: Toward a Better Classification System for NK-LGL Disorders.
reftext: Gaëlle Drillet, et al. Front Oncol. 2022;12:821382.
year: '2022'
doi: 10.3389/fonc.2022.821382
journal_title: Frontiers in Oncology
journal_nlm_ta: Front Oncol
publisher_name: Frontiers Media S.A.
keywords: chronic lymphoproliferative disorders of NK cells | NK cells | KIR phenotype
  | STAT3 | large granular lymphocyte leukemia
automl_pathway: 0.9520548
figid_alias: PMC8843930__F1
figtype: Figure
organisms_ner:
- Mus musculus
- Homo sapiens
redirect_from: /figures/PMC8843930__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8843930__fonc-12-821382-g001.html
  '@type': Dataset
  description: Signaling pathways and mutations involved in NK-LGL leukemia pathogenesis.
    STAT3, RAS/MAPK and PI3K/AKT pathways are constitutionally activated in NK-LGL
    leukemia. The PI3K/AKT pathway leads to the activation of m-TOR and NFκB. STAT3
    and NFκB promote the transcription of anti-apoptotic genes such as bcl-2 ou mcl-1.
    TNFAIP3 can undergo an inactivating mutation of the A20 protein that negatively
    regulates NFκB. LGLs are resistant to Fas mediated apoptosis. A TET2 loss-of-function
    mutation is found in 34% of NK-LGLs. The gene encoding the chemokine CCL22 is
    mutated in 20% of NK-LGLs. Fas, First Apoptosis Signal; FasL, FasLigand; IL, interleukin;
    IL-R, interleukin-receptor; Jak, Janus Kinase; STAT3, Signal transducer and activator
    of transcription 3; PDGF-BB, platelet-derived growth factor BB; MEK, mitogen activated
    protein kinase; ERK, extracellular-signal-regulated kinase; PI3K, phosphatidyl
    Inositol 3-Kinase; mTOR, mammalian target of rapamycin; NFκB, nuclear factor kappa
    B; Mcl1, Myeloid cell leukemia1; Bcl, B-cell lymphoma 2; CCL22, C-C Motif Chemokine
    Ligand 22; 5-mc, 5-methylcytosin; 5hmc, 5-hydroxymethylcytosin; TET2, Ten-eleven-translocation
    2.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Il15
  - Il6
  - ras
  - Hras
  - Kras
  - Rem1
  - Il6ra
  - Zhx2
  - Fasl
  - Pik3r1
  - Mdk
  - Ephb2
  - Mapk1
  - Akt1
  - Fas
  - Fasn
  - Mtor
  - Pdgfrb
  - Stat3
  - Nfkb1
  - Tnfaip3
  - Tet2
  - mc
  - Ifnl3
  - Mcl1
  - Bcl2
  - Bc1
  - Bc1-ps1
  - Igkv1-136
  - Myc
  - Nol3
  - Ccl2
  - PDGFB
  - IL15
  - IL6
  - KRAS
  - HRAS
  - NRAS
  - IL6R
  - JAK1
  - JAK2
  - JAK3
  - TYK2
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - FASLG
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - EPHB2
  - MAPK1
  - MAPK3
  - AKT1
  - AKT2
  - AKT3
  - FAS
  - FASN
  - MTOR
  - PDGFRB
  - PDGFRA
  - STAT3
  - NFKB1
  - RELA
  - RELB
  - REL
  - NFKB2
  - TNFAIP3
  - IGKV1-27
  - TET2
  - IFNA17
  - MCL1
  - BCL2
  - CHMP2A
  - MYC
  - CCNE1
  - CCNE2
  - CCL2
---
